Publication

Go to Publication

Continue Reading COVID-19 care in India: the course to self-reliance

Abstract Background: Multidrug-resistant tuberculosis (MDR-TB) is an increasing problem worldwide, and 24% occurs in India. Linezolid is associated with improved MDR-TB treatment outcomes but causes significant side-effects and…

Continue Reading Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India

Abstract Background: Interstitial lung disease (ILD) is a complex and heterogeneous group of acute and chronic lung diseases of several known and unknown causes. While clinical practice guidelines…

Continue Reading Management of interstitial lung diseases: A consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP)

Abstract The present COVID-19 pandemic, caused by the airborne SARS-CoV-2 virus, has highlighted the vital importance of appropriate personal protective equipment for all exposed health care workers. The…

Continue Reading The N-95 mask: invaluable ally in the battle against the COVID-19 pandemic

Abstract Whilst COVID-19 infection generally run a mild course in up to 80% of those affected, a number of pre-existing co-morbidities determine the severity of infection and the…

Continue Reading Prognostic Factors for Adverse Outcomes in COVID-19 Infection

Abstract Chloroquine and Hydroxychloroquine are drugs which have been widely used in malaria and rheumatoid arthritis respectively for over 50 years. There was anecdotal evidence of their efficacy…

Continue Reading Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?

Abstract Clofazimine (CFZ), an old hydrophobic riminophenazine, has a wide range of antimycobacterial activity ranging from leprosy to nontuberculous mycobacterial diseases. CFZ has several advantages such as a…

Continue Reading Clofazimine: an old drug for never-ending diseases

Go to Publication

Continue Reading How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus

Abstract Background: Treatment of multidrug-resistant tuberculosis requires long-term therapy with a combination of multiple second-line drugs. These drugs are associated with numerous adverse events that can cause severe…

Continue Reading Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

Go to Publication

Continue Reading Challenging the management of drug-resistant tuberculosis – Authors’ reply